Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat

  • Fluidigm Corp FLDM posted Q3 revenues of $28.5 million, down 29% Y/Y, missing the consensus of $30.00 million, citing supply chain issues affecting product fulfillment.
  • Fluidigm is undertaking a review of various options to maximize shareholder value, including strategic alternatives, cost & capital structure, and operations and supply chain. 
  • Fluidigm's Q3 product revenues fell 25% to $21.9 million, while its service revenues dropped about 2% to $6.0 million.
  • Base product and service revenue, excluding COVID-19 testing, was up about 2% to $25.6 million from $25.1 million last year.
  • The company noted that demand in the APAC region was impacted by tax permit issues in China and COVID-related shutdowns in Japan.
  • Fluidigm's Q3 net loss ballooned to $(13.8) million, compared to a net loss of $(6.0) million last year.
  • The adjusted net loss per share was $(0.07), beating the consensus of $(0.22) and a turnaround from EPS of $0.03 a year ago.
  • The company finished the quarter with $30.3 million in cash and cash equivalents.
  • Guidance: Fluidigm revised its 2021 guidance downward, noting that it now expects FY21 revenues of $123 million - $127 million (consensus $137 million) compared to a previous range of $134 million - $140 million
  • The company also expects to incur a net loss of $(63) million - $(66) million for the year.
  • For Q4, Fluidigm expects total revenue of $31 million - $34 million, below the consensus of $43.2 million.
  • Price Action: FLDM shares closed 1.23% lower at $4.82 on Monday.
Market News and Data brought to you by Benzinga APIs
Posted In: EarningsNewsPenny StocksGuidanceHealth CareSmall CapMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!